Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-10 01:38:52 EDT

Explore

PostsPeople
LatestRanked
@discoveripo.bsky.socialOct 10, 2026, 8:00 AM

news reports say CITY THERAPEUTICS, INC. is expected to list on October 12, 2026
City Therapeutics, Inc. is expected to list on October 12, 2026, as reported by news sources. The biotech company focuses on RNA interference…
Biotech

#IPO #Biotech #PharmaceuticalPreparations #UnitedStates #IPONews

@discoveripo.bsky.socialOct 10, 2026, 12:00 AM

BirchBioMed Inc. filed for an IPO
BirchBioMed Inc. has filed for an IPO. The Canadian biotech firm focuses on treatments for scarring and autoimmune diseases, developing technologies for conditions…
Biotech

#IPO #Biotech #PharmaceuticalPreparations #Canada #IPONews #pharmaceuticals #clinicalstage

@discoveripo.bsky.socialOct 9, 2026, 12:04 PM

CITY THERAPEUTICS, INC. filed for an IPO
City Therapeutics, Inc., a biotech firm focused on RNAi therapeutics, has filed for an IPO. The company aims to address unmet medical needs.
Biotech

#IPO #Biotech #PharmaceuticalPreparations #UnitedStates #IPONews #RNAinterference

@discoveripo.bsky.socialOct 6, 2026, 7:04 AM

news reports say Retension Pharmaceuticals, Inc. is expected to list on October 9, 2026
Retension Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, is expected…
Biotech

#IPO #Biotech #PharmaceuticalPreparations #UnitedStates #IPONews #pharmaceuticals #PDE5inhibitors #cardiovascular

@discoveripo.bsky.socialOct 5, 2026, 1:01 PM

Retension Pharmaceuticals, Inc. filed for an IPO
Retension Pharmaceuticals has filed for an IPO, focusing on treatments for hypertension. Their lead candidate, RTN-001, is designed to…
Biotech

#IPO #Biotech #PharmaceuticalPreparations #UnitedStates #IPONews #pharmaceuticals #cardiovascular

@discoveripo.bsky.socialSep 28, 2026, 12:03 PM

ADARx Pharmaceuticals, Inc. priced its IPO
ADARx Pharmaceuticals, Inc. has priced its IPO in the biotech sector at $17.00 per share. It is anticipated to list on September 28, 2026.
Biotech

#IPO #Biotech #PharmaceuticalPreparations #UnitedStates #IPONews

@discoveripo.bsky.socialSep 16, 2026, 11:07 PM

NuvOx Therapeutics, Inc. filed for an IPO
Biotech

#IPO #Biotech #PharmaceuticalPreparations #UnitedStates #IPONews

@discoveripo.bsky.socialSep 14, 2026, 10:04 PM

ADARx Pharmaceuticals, Inc. filed for an IPO
ADARx Pharmaceuticals has filed for an IPO. The biotech firm is focused on innovative siRNA therapeutics for various diseases, including obesity and neurodegenerative…
Biotech

#IPO #Biotech #PharmaceuticalPreparations #UnitedStates #IPONews #siRNA